Research graph
References from Investigating the impact of margins on the management of oropharyngeal cancer treated with transoral robotic surgery: a survey of head and neck oncologists’ treatment patterns. Local targets link to admitted publications; unresolved targets remain external evidence.
Functional outcomes after TORS for oropharyngeal cancer: a systematic review
2015 · External reference
Oncologic outcomes after transoral robotic surgery: a multi-institutional study
10.1001/jamaoto.2015.1508 · 2015 · External reference
Differences in functional and survival outcomes between patients receiving primary surgery vs chemoradiation therapy for treatment of T1-T2 oropharyngeal squamous cell carcinoma
10.1001/jamaoto.2023.1944 · 2023 · External reference
The effect of the surgical margins on the outcome of patients with head and neck squamous cell carcinoma: single institution experience
2012 · External reference
The significance of “positive” margins in surgically resected epidermoid carcinomas
10.1002/hed.2890010203 · 1978 · External reference
Determination of posterolateral oropharyngeal wall thickness and the potential implications for transoral surgical margins in tonsil cancer
10.1002/hed.26693 · 2021 · External reference
Impact of margins on outcomes in HPV-related oropharyngeal squamous cell carcinoma treated with surgery only
10.1002/ohn.1213 · 2025 · External reference
Margin status and recurrence in surgically treated patients with HPV + oropharyngeal cancer
10.1002/lary.32091 · 2025 · External reference
Specimen-based resection margins and local control during transoral robotic surgery for oropharyngeal HPV-mediated squamous cell carcinoma
10.1159/000527369 · 2023 · External reference
Transoral robotic surgery without adjuvant therapy: a systematic review and meta-analysis of the association between surgical margins and local recurrence
10.1016/j.oraloncology.2023.106610 · 2023 · External reference
A systematic review and meta-analysis of margins in transoral surgery for oropharyngeal carcinoma
10.1016/j.oraloncology.2019.09.017 · 2019 · External reference
Surgical margin determination in the Era of HPV ‐positive oropharyngeal cancer
10.1002/lary.29533 · 2021 · External reference
Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: national cancer data base
10.1002/cncr.29938 · 2016 · External reference
Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311)
10.1200/jco.21.01752 · 2022 · External reference
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
10.1186/s12885-015-1598-x · 2015 · External reference
Long-term follow-up of E3311, an ECOG-ACRIN cancer research group phase II trial of transoral surgery and risk-based adjuvant treatment in human papillomavirus-initiated oropharynx cancer
10.1200/jco-24-02550 · 2025 · External reference
The effect of tumor margin status on progression-free survival (PFS) in patients with oropharyngeal squamous cell carcinoma (OPSCC) after transoral robotic surgery (TORS)
10.1016/j.ijrobp.2022.07.1389 · 2022 · External reference
“Close then Clear” margins in transoral resection of p16+ oropharyngeal squamous cell carcinoma
10.1002/ohn.70032 · 2025 · External reference
Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: influence of resection margins on oncological outcomes
10.1016/j.oraloncology.2022.105909 · 2022 · External reference
Oropharyngeal carcinoma treated with surgery alone: outcomes and predictors of failure
10.1177/00034894211021287 · 2022 · External reference
Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control
10.1001/archoto.2012.1166 · 2012 · External reference
Diagnostic accuracy of intraoperative margin assessment techniques in surgery for head and neck squamous cell carcinoma: a meta-analysis
10.1016/j.oraloncology.2023.106419 · 2023 · External reference
Use of intraoperative frozen section to assess surgical margins in HPV-related oropharyngeal carcinoma
10.1001/jamaoto.2024.4869 · 2025 · External reference
Frozen section evaluation of margin status in primary squamous cell carcinomas of the head and neck: a correlation study of frozen section and final diagnoses
10.1007/s12105-017-0846-6 · 2018 · External reference
Defining the prevalence and prognostic value of perineural invasion and angiolymphatic invasion in human papillomavirus-positive oropharyngeal carcinoma
10.1001/jamaoto.2017.2019 · 2017 · External reference
NCCN guidelines® insights: head and neck cancers Version 12022
10.6004/jnccn.2022.0016 · 2022 · External reference
Transoral robotic surgery and neck dissection for HPV-positive oropharyngeal carcinoma: importance of nodal count in survival
10.1016/j.oraloncology.2020.104770 · 2020 · External reference
Transoral robotic surgery in the multidisciplinary care of patients with oropharyngeal squamous cell carcinoma: ASCO guideline
10.1200/jco-24-02755 · 2025 · External reference
A phase 2 trial of alternative volumes of oropharyngeal irradiation for de-intensification (AVOID): omission of the resected primary tumor bed after transoral robotic surgery for human papilloma virus-related squamous cell carcinoma of the oropharynx
10.1016/j.ijrobp.2019.11.021 · 2020 · External reference
Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer
10.1200/jco.19.02444 · 2020 · External reference
Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal cancer
10.1158/1078-0432.ccr-19-0211 · 2019 · External reference
Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma
10.1158/1078-0432.ccr-22-0562 · 2022 · External reference
Circulating tumor HPV DNA for surveillance of HPV-positive oropharyngeal squamous cell carcinoma: a narrative review
10.1001/jamaoncol.2023.4042 · 2023 · External reference
Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation
10.1016/j.oraloncology.2021.105332 · 2021 · External reference
Postoperative human papilloma virus circulating tumor DNA guided adjuvant therapy for human papilloma virus-related oropharyngeal carcinoma (PATH Study)
10.1016/j.ijrobp.2025.09.044 · 2026 · External reference
Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control
10.1001/archoto.2012.1166 · ExternalCitation · doi-reference
Circulating tumor HPV DNA for surveillance of HPV-positive oropharyngeal squamous cell carcinoma: a narrative review
10.1001/jamaoncol.2023.4042 · ExternalCitation · doi-reference
Oncologic outcomes after transoral robotic surgery: a multi-institutional study
10.1001/jamaoto.2015.1508 · ExternalCitation · doi-reference
Defining the prevalence and prognostic value of perineural invasion and angiolymphatic invasion in human papillomavirus-positive oropharyngeal carcinoma
10.1001/jamaoto.2017.2019 · ExternalCitation · doi-reference
Differences in functional and survival outcomes between patients receiving primary surgery vs chemoradiation therapy for treatment of T1-T2 oropharyngeal squamous cell carcinoma
10.1001/jamaoto.2023.1944 · ExternalCitation · doi-reference
Use of intraoperative frozen section to assess surgical margins in HPV-related oropharyngeal carcinoma
10.1001/jamaoto.2024.4869 · ExternalCitation · doi-reference
Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: national cancer data base
10.1002/cncr.29938 · ExternalCitation · doi-reference
Determination of posterolateral oropharyngeal wall thickness and the potential implications for transoral surgical margins in tonsil cancer
10.1002/hed.26693 · ExternalCitation · doi-reference
The significance of “positive” margins in surgically resected epidermoid carcinomas
10.1002/hed.2890010203 · ExternalCitation · doi-reference
Surgical margin determination in the Era of HPV ‐positive oropharyngeal cancer
10.1002/lary.29533 · ExternalCitation · doi-reference
Margin status and recurrence in surgically treated patients with HPV + oropharyngeal cancer
10.1002/lary.32091 · ExternalCitation · doi-reference
Impact of margins on outcomes in HPV-related oropharyngeal squamous cell carcinoma treated with surgery only
10.1002/ohn.1213 · ExternalCitation · doi-reference
“Close then Clear” margins in transoral resection of p16+ oropharyngeal squamous cell carcinoma
10.1002/ohn.70032 · ExternalCitation · doi-reference
Frozen section evaluation of margin status in primary squamous cell carcinomas of the head and neck: a correlation study of frozen section and final diagnoses
10.1007/s12105-017-0846-6 · ExternalCitation · doi-reference
A phase 2 trial of alternative volumes of oropharyngeal irradiation for de-intensification (AVOID): omission of the resected primary tumor bed after transoral robotic surgery for human papilloma virus-related squamous cell carcinoma of the oropharynx
10.1016/j.ijrobp.2019.11.021 · ExternalCitation · doi-reference
The effect of tumor margin status on progression-free survival (PFS) in patients with oropharyngeal squamous cell carcinoma (OPSCC) after transoral robotic surgery (TORS)
10.1016/j.ijrobp.2022.07.1389 · ExternalCitation · doi-reference
Postoperative human papilloma virus circulating tumor DNA guided adjuvant therapy for human papilloma virus-related oropharyngeal carcinoma (PATH Study)
10.1016/j.ijrobp.2025.09.044 · ExternalCitation · doi-reference
A systematic review and meta-analysis of margins in transoral surgery for oropharyngeal carcinoma
10.1016/j.oraloncology.2019.09.017 · ExternalCitation · doi-reference
Transoral robotic surgery and neck dissection for HPV-positive oropharyngeal carcinoma: importance of nodal count in survival
10.1016/j.oraloncology.2020.104770 · ExternalCitation · doi-reference
Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation
10.1016/j.oraloncology.2021.105332 · ExternalCitation · doi-reference
Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: influence of resection margins on oncological outcomes
10.1016/j.oraloncology.2022.105909 · ExternalCitation · doi-reference
Diagnostic accuracy of intraoperative margin assessment techniques in surgery for head and neck squamous cell carcinoma: a meta-analysis
10.1016/j.oraloncology.2023.106419 · ExternalCitation · doi-reference
Transoral robotic surgery without adjuvant therapy: a systematic review and meta-analysis of the association between surgical margins and local recurrence
10.1016/j.oraloncology.2023.106610 · ExternalCitation · doi-reference
Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal cancer
10.1158/1078-0432.ccr-19-0211 · ExternalCitation · doi-reference
Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma
10.1158/1078-0432.ccr-22-0562 · ExternalCitation · doi-reference
Specimen-based resection margins and local control during transoral robotic surgery for oropharyngeal HPV-mediated squamous cell carcinoma
10.1159/000527369 · ExternalCitation · doi-reference
Oropharyngeal carcinoma treated with surgery alone: outcomes and predictors of failure
10.1177/00034894211021287 · ExternalCitation · doi-reference
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
10.1186/s12885-015-1598-x · ExternalCitation · doi-reference
Long-term follow-up of E3311, an ECOG-ACRIN cancer research group phase II trial of transoral surgery and risk-based adjuvant treatment in human papillomavirus-initiated oropharynx cancer
10.1200/jco-24-02550 · ExternalCitation · doi-reference
Transoral robotic surgery in the multidisciplinary care of patients with oropharyngeal squamous cell carcinoma: ASCO guideline
10.1200/jco-24-02755 · ExternalCitation · doi-reference
Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer
10.1200/jco.19.02444 · ExternalCitation · doi-reference
Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311)
10.1200/jco.21.01752 · ExternalCitation · doi-reference
NCCN guidelines® insights: head and neck cancers Version 12022
10.6004/jnccn.2022.0016 · ExternalCitation · doi-reference
